BioSpace News Archive

Synapse Medical Communications (Synapse), a leader in analytics-driven commercialization solutions, announced that its “BiomARker Experience Augmented Reality” application has been named a finalist for the 2019 PM360 Trailblazer Initiative Awards, in the Healthcare Provider Education category.

Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:45 a.m. British Summer Time on Wednesday, Sept. 18, 2019, in London.

Aurinia Pharmaceuticals Inc. announced that it has entered into an Open Market Sales Agreement with Jefferies LLC pursuant to which the Company may from time to time sell, through at-the-market offerings with Jefferies acting as sales agent, such common shares as would have an aggregate offer price of up to US$40,000,000.

Health Canada is informing Canadians that it is aware that the impurity N-nitrosodimethylamine has been detected in some ranitidine drugs.

FINNEA Group, LLC is pleased to announce the successful growth financing capital raise by Xoran Holdings LLC.

Achieve Life Sciences, Inc. announced that two presentations featuring final data from the Phase 2b ORCA-1 trial will be conducted at the SRNT-E Annual Conference on Friday, September 13th in Oslo.

Retrospective Findings Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 24th Annual Conference of Rehabilitation in Multiple Sclerosis

Imara Inc. announced that it has previously confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

Alkermes plc announced the appointment of two new independent directors, Richard Gaynor, M.D. and Frank Anders Wilson, to the company’s Board of Directors.

Aimmune Therapeutics, Inc. announced that NASDAQ has halted trading of the company’s common stock.